ALC241220P87500
- 1.63
- +0.68+71.58%
Alcon Newsroom
Why Alcon (ALC) Is a Top Growth Stock for the Long-Term
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $107.55
Alcon Inc.'s (VTX:ALC) Intrinsic Value Is Potentially 39% Above Its Share Price
Alcon Inc. (ALC): A Bull Case Theory
Analysts Are Bullish on Top Healthcare Stocks: Haemonetics (HAE), Alcon (ALC)
Top Gap Ups and Downs on Tuesday: LLY, ZM, BBY and More
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $107.25
India Contact Lenses Market Forecasts and Company Analysis Report 2023-2024 & 2032 Featuring Bausch & Lomb, Alcon Laboratories, J&J, Cooper Vision, Carl Zeiss, Hoya Medical, GKB Ophthalmic and Omni
3 'Buy' Stocks and 2 'Hold' Stocks According to Oppenheimer
Impressive Earnings May Not Tell The Whole Story For Alcon (VTX:ALC)
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $92.9
Alcon Price Target Lowered to CHF 82 From CHF 85 at Deutsche Bank
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Orbis International Brings the Flying Eye Hospital to Bangladesh to Improve Eye Care
J.P. Morgan Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $89.5
Alcon Management to Meet With BTIG
Analysts Conflicted on These Healthcare Names: Alcon (ALC), Innate Pharma SA (OtherIPHYF) and ScPharmaceuticals (SCPH)
BofA Securities Maintains Alcon(ALC.US) With Hold Rating, Cuts Target Price to $93.63
Jefferies Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $100
A Quick Look at Today's Ratings for Alcon(ALC.US), With a Forecast Between $93.63 to $107